This bill aims to enhance diabetes management in Florida schools by allowing school districts and public schools to acquire and maintain a supply of undesignated glucagon for emergency use in treating students experiencing hypoglycemic episodes. The bill defines key terms such as "authorized health care practitioner," "participating school," and "undesignated glucagon." It mandates that glucagon be stored securely yet be immediately accessible to trained personnel, and it allows schools to obtain glucagon through various means, including donations, grants, or arrangements with suppliers. Additionally, the bill requires schools to make glucagon available as per students' diabetes management plans and outlines the responsibilities of school personnel in administering glucagon and notifying parents or guardians after its use.

Furthermore, the bill provides legal immunity to school personnel and health care practitioners who administer glucagon in good faith, protecting them from civil or criminal liability. It also emphasizes the need for training for school staff in diabetes care and establishes that school districts cannot restrict the assignment of diabetic students based on their condition or the availability of nursing staff. The State Board of Education is tasked with adopting rules to implement these provisions, ensuring that schools are equipped to manage diabetes effectively and safely. The act is set to take effect on July 1, 2025.

Statutes affected:
S 772 Filed: 1002.20
S 772 c1: 1002.20